Anderson J. Ryan
Roosevelt Drive
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
An organotypic model for investigating drug-radiation responses in the lung.
Journal: Journal of biological methods
Published: September 06, 2024
Orthotopic and metastatic tumour models in preclinical cancer research.
Journal: Pharmacology & therapeutics
Published: August 17, 2023
iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.
Journal: Journal of cell science
Published: February 22, 2022
Using oxygen dose histograms to quantify voxelised ultra-high dose rate (FLASH) effects in multiple radiation modalities.
Journal: Physics in medicine and biology
Published: November 05, 2021
The cell-line-derived subcutaneous tumor model in preclinical cancer research.
Journal: Nature protocols
Published: September 05, 2021
Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours.
Journal: EMBO molecular medicine
Published: May 06, 2021
CHK1 inhibition exacerbates replication stress induced by IGF blockade.
Journal: Oncogene
Published: May 04, 2021
DNAPK Inhibition Preferentially Compromises the Repair of Radiation-induced DNA Double-strand Breaks in Chronically Hypoxic Tumor Cells in Xenograft Models.
Journal: Molecular cancer therapeutics
Published: October 06, 2020
Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 22, 2020
Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction.
Journal: Cancer research
Published: August 23, 2020
Olaparib increases the therapeutic index of hemithoracic irradiation compared with hemithoracic irradiation alone in a mouse lung cancer model.
Journal: British journal of cancer
Published: June 16, 2020
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Journal: Clinical and translational radiation oncology
Published: April 21, 2020
Last Updated: 09/26/2026